 |
| Dr Fabien Vincent |
Actually, someone is doing something about it. I keep saying that my heroes wear lab-coats. These are the people who are quietly working to improve the lives, and even save the lives, of lupies around the world. (With six million of us world-wide, every step forward in lupus research means a lot to a lot of people.)
One of those heroes is Dr Fabien Vincent from the Rheumatology Research Group at Monash University.
One of those heroes is Dr Fabien Vincent from the Rheumatology Research Group at Monash University.
Dr Vincent was recently awarded a Rebecca L Cooper Medical Research Foundation Grant for identifying molecular signatures in Indigenous Australians with lupus.
He said, "We ultimately aim to improve our understanding of treatment of lupus to develop a more targeted and personalised medicine for patients, and help to close the health gap between Indigenous and non-Indigenous Australian lupus sufferers."
You can find more information about this project here
He has provided a list of some of the recent publications related to his and the Monash team's lupus research. Here's the list:
Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F and Morand EF. Urinary B Cell-Activating Factor of the Tumor Necrosis Factor Family (BAFF) in Systemic Lupus Erythematosus. Lupus 2018; 27:2029-40
Mende R†, Vincent FB†, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi A, Morand EF, Harris J† and Lang T†. Analysis of Serum Interleukin (IL)-1b and IL-18 in Systemic LupusErythematosus. Front Immunol 2018; 9:1250
† Equal contributors
Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, Kandane-Rathnayake R and Morand EF. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus. Lupus Sci Med 2018; doi: 10.1136/lupus-2018-000277
Vincent FB†, Lin E†, Sahhar J, Ngian GS, Kandane-Rathnayake R, Mende R, Hoi AY, Morand EF, Lang T†, Harris J†. Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis. Clin Transl Immunology 2018; 7:e1042
† Equal contributors
Vincent FB†, Nim H†, Thomas JPW, Morand EF† and Harris J†. Effect of storage duration on cytokine stability in human serum and plasma. Cytokine 2019; 113:453-7
† Equal contributors
Vincent FB, Bubicich M, Downie-Doyle S, Mackay F, Morand EF and Rischmueller M. Serum soluble Fas and Fas ligand(FasL) in Primary Sjögren’s Syndrome. Clin Exp Rheumatol 2019
Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F and Morand EF. Urinary B Cell-Activating Factor of the TumorNecrosis Factor Family (BAFF) in Systemic LupusErythematosus. Lupus 2018; 27:2029-40
Mende R†, Vincent FB†, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi A, Morand EF, Harris J† and Lang T†. Analysis of Serum Interleukin (IL)-1b and IL-18 in Systemic LupusErythematosus. Front Immunol 2018; 9:1250
† Equal contributors
Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, Kandane-Rathnayake R and Morand EF. Analysis of urinary macrophage migration inhibitory factor in systemic lupuserythematosus. Lupus Sci Med 2018; doi: 10.1136/lupus-2018-000277
Vincent FB†, Lin E†, Sahhar J, Ngian GS, Kandane-Rathnayake R, Mende R, Hoi AY, Morand EF, Lang T†, Harris J†. Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis. Clin Transl Immunology 2018; 7:e1042
† Equal contributors
Vincent FB†, Nim H†, Thomas JPW, Morand EF† and Harris J†. Effect of storage duration on cytokine stability in human serum and plasma. Cytokine 2019; 113:453-7
† Equal contributors
Vincent FB, Bubicich M, Downie-Doyle S, Mackay F, Morand EF and Rischmueller M. Serum soluble Fas and Fas ligand(FasL) in Primary Sjögren’s Syndrome. Clin Exp Rheumatol 2019
Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Hoi AY, Harris J, Mackay F and Morand EF. Analysisof serum B cell-activating factor from the tumor necrosis factor family (BAFF)and its soluble receptors in systemic lupus erythematosus. Clin Transl Immunology 2019; 8:e01047
Mende R†, Vincent FB†, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi A, Morand EF, Harris J† and Lang T†. Analysis of Serum Interleukin (IL)-1b and IL-18 in Systemic LupusErythematosus. Front Immunol 2018; 9:1250
† Equal contributors
Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, Kandane-Rathnayake R and Morand EF. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus. Lupus Sci Med 2018; doi: 10.1136/lupus-2018-000277
Vincent FB†, Lin E†, Sahhar J, Ngian GS, Kandane-Rathnayake R, Mende R, Hoi AY, Morand EF, Lang T†, Harris J†. Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis. Clin Transl Immunology 2018; 7:e1042
† Equal contributors
Vincent FB†, Nim H†, Thomas JPW, Morand EF† and Harris J†. Effect of storage duration on cytokine stability in human serum and plasma. Cytokine 2019; 113:453-7
† Equal contributors
Vincent FB, Bubicich M, Downie-Doyle S, Mackay F, Morand EF and Rischmueller M. Serum soluble Fas and Fas ligand(FasL) in Primary Sjögren’s Syndrome. Clin Exp Rheumatol 2019
Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F and Morand EF. Urinary B Cell-Activating Factor of the TumorNecrosis Factor Family (BAFF) in Systemic LupusErythematosus. Lupus 2018; 27:2029-40
Mende R†, Vincent FB†, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi A, Morand EF, Harris J† and Lang T†. Analysis of Serum Interleukin (IL)-1b and IL-18 in Systemic LupusErythematosus. Front Immunol 2018; 9:1250
† Equal contributors
Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, Kandane-Rathnayake R and Morand EF. Analysis of urinary macrophage migration inhibitory factor in systemic lupuserythematosus. Lupus Sci Med 2018; doi: 10.1136/lupus-2018-000277
Vincent FB†, Lin E†, Sahhar J, Ngian GS, Kandane-Rathnayake R, Mende R, Hoi AY, Morand EF, Lang T†, Harris J†. Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis. Clin Transl Immunology 2018; 7:e1042
† Equal contributors
Vincent FB†, Nim H†, Thomas JPW, Morand EF† and Harris J†. Effect of storage duration on cytokine stability in human serum and plasma. Cytokine 2019; 113:453-7
† Equal contributors
Vincent FB, Bubicich M, Downie-Doyle S, Mackay F, Morand EF and Rischmueller M. Serum soluble Fas and Fas ligand(FasL) in Primary Sjögren’s Syndrome. Clin Exp Rheumatol 2019
Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Hoi AY, Harris J, Mackay F and Morand EF. Analysisof serum B cell-activating factor from the tumor necrosis factor family (BAFF)and its soluble receptors in systemic lupus erythematosus. Clin Transl Immunology 2019; 8:e01047
I have to admit some of those articles are over my head (right, I admit it, all of them are over my head, my degrees are in a very different field) - but that's OK - I don't have to understand the details, I just appreciate that someone who does understand is doing the work.
If you want to read something of Dr Vincent's that is easier for non-scientists to read, here are some of his articles (originally from The Conversation) that have been republished here at sometimesitislupus.com :
The tenth of May is World Lupus Day - if you want to mark the day by doing something positive to help people with lupus, you might want to donate to lupus research at Monash or other Australian Universities. You can find donation links in the right-hand column of this blog.
